ID

13561

Descripción

A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3); ODM derived from: https://clinicaltrials.gov/show/NCT01471340

Link

https://clinicaltrials.gov/show/NCT01471340

Palabras clave

Versiones (1)
  1. 15/2/16 15/2/16 -
Subido en

15 de febrero de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Asthma NCT01471340

Inglés

Eligibility Asthma NCT01471340

1 formularios  
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT01471340
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
persistent asthma for at least 1-year
Descripción

persistent asthma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3266628
must use a daily asthma controller medication for at least 4 weeks prior to randomization, including an inhaled corticosteroid (ics) with or without a long-acting beta agonist (laba) or other adjunctive asthma therapy or be using a leukotriene receptor antagonist (ltra), xanthine or short acting beta agonist (saba) as a monotherapy.
Descripción

asthma therapy; corticosteroid

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0004096
UMLS CUI [2]
C3536709
must be able to discontinue current asthma medication
Descripción

medication asthma

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0004096
must have a history of at least one asthma exacerbation in previous 4 to 52 weeks
Descripción

asthma exacerbation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0349790
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
unstable asthma
Descripción

Unstable status asthma

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0443343
UMLS CUI [1,2]
C0004096
taking high dose ics with or without other adjunctive therapy who have an asthma control questionnaire 6 (acq6) total score ≥ 1.5
Descripción

corticosteroid; Adjuvant therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001617
UMLS CUI [2]
C0677850
taking ltra, xanthine or saba monotherapy with an acq-6 total score < 1.5 (controlled)
Descripción

xanthine

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3541955
chronic obstructive pulmonary disease (copd), cystic fibrosis (cf), or other significant, non-asthmatic, lung disease
Descripción

comorbidity Lung diseases

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0024115
clinically significant abnormality, illness or disorder of any body or organ system
Descripción

comorbidity

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009488
significant underlying cardiovascular condition which may contraindicate use of a beta-agonist.
Descripción

comorbidity Cardiovascular Diseases; medication contraindication beta agonist

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0007222
UMLS CUI [2,1]
C3699431
UMLS CUI [2,2]
C0001644
history of smoking greater than 10-pack years
Descripción

smoking status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1519386
had an asthma exacerbation within 4 weeks of the baseline visit
Descripción

asthma exacerbation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0349790
had more than 4 asthma exacerbations or 2 hospitalizations within 52 weeks of the randomization visit
Descripción

asthma exacerbation hospitalization

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0349790
UMLS CUI [1,2]
C0019993
known or suspected hypersensitivity or intolerance to corticosteroids, beta-2 agonists, or any of the (inactive ingredients) excipients present in the medications used in this study
Descripción

hypersensitivity corticosteroids

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0001617
require the use of chronic systemic steroids, omalizumab, or other monoclonal or polyclonal antibodies
Descripción

antibodies; systemic steroids

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0003241
UMLS CUI [2]
C2825233
requires the use of beta-blockers
Descripción

beta-blockers

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0304516
history of life-threatening asthma, including an asthma episode that required intubation and/or was associated with hypercapnia requiring noninvasive ventilatory support
Descripción

severe asthma; intubation; hypercapnia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0581126
UMLS CUI [2]
C0021925
UMLS CUI [3]
C0020440
lactating, pregnant, or plans to become pregnant during the course of the trial
Descripción

pregnancy; lactating

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Volver a la parte superior de la página

Similar models

Eligibility Asthma NCT01471340

1 formularios
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT01471340
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
persistent asthma
Item
persistent asthma for at least 1-year
boolean
C3266628 (UMLS CUI [1])
asthma therapy; corticosteroid
Item
must use a daily asthma controller medication for at least 4 weeks prior to randomization, including an inhaled corticosteroid (ics) with or without a long-acting beta agonist (laba) or other adjunctive asthma therapy or be using a leukotriene receptor antagonist (ltra), xanthine or short acting beta agonist (saba) as a monotherapy.
boolean
C0087111 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
C3536709 (UMLS CUI [2])
medication asthma
Item
must be able to discontinue current asthma medication
boolean
C0013227 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
asthma exacerbation
Item
must have a history of at least one asthma exacerbation in previous 4 to 52 weeks
boolean
C0349790 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Unstable status asthma
Item
unstable asthma
boolean
C0443343 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
corticosteroid; Adjuvant therapy
Item
taking high dose ics with or without other adjunctive therapy who have an asthma control questionnaire 6 (acq6) total score ≥ 1.5
boolean
C0001617 (UMLS CUI [1])
C0677850 (UMLS CUI [2])
xanthine
Item
taking ltra, xanthine or saba monotherapy with an acq-6 total score < 1.5 (controlled)
boolean
C3541955 (UMLS CUI [1])
comorbidity Lung diseases
Item
chronic obstructive pulmonary disease (copd), cystic fibrosis (cf), or other significant, non-asthmatic, lung disease
boolean
C0009488 (UMLS CUI [1,1])
C0024115 (UMLS CUI [1,2])
comorbidity
Item
clinically significant abnormality, illness or disorder of any body or organ system
boolean
C0009488 (UMLS CUI [1])
comorbidity Cardiovascular Diseases; medication contraindication beta agonist
Item
significant underlying cardiovascular condition which may contraindicate use of a beta-agonist.
boolean
C0009488 (UMLS CUI [1,1])
C0007222 (UMLS CUI [1,2])
C3699431 (UMLS CUI [2,1])
C0001644 (UMLS CUI [2,2])
smoking status
Item
history of smoking greater than 10-pack years
boolean
C1519386 (UMLS CUI [1])
asthma exacerbation
Item
had an asthma exacerbation within 4 weeks of the baseline visit
boolean
C0349790 (UMLS CUI [1])
asthma exacerbation hospitalization
Item
had more than 4 asthma exacerbations or 2 hospitalizations within 52 weeks of the randomization visit
boolean
C0349790 (UMLS CUI [1,1])
C0019993 (UMLS CUI [1,2])
hypersensitivity corticosteroids
Item
known or suspected hypersensitivity or intolerance to corticosteroids, beta-2 agonists, or any of the (inactive ingredients) excipients present in the medications used in this study
boolean
C0020517 (UMLS CUI [1,1])
C0001617 (UMLS CUI [1,2])
antibodies; systemic steroids
Item
require the use of chronic systemic steroids, omalizumab, or other monoclonal or polyclonal antibodies
boolean
C0003241 (UMLS CUI [1])
C2825233 (UMLS CUI [2])
beta-blockers
Item
requires the use of beta-blockers
boolean
C0304516 (UMLS CUI [1])
severe asthma; intubation; hypercapnia
Item
history of life-threatening asthma, including an asthma episode that required intubation and/or was associated with hypercapnia requiring noninvasive ventilatory support
boolean
C0581126 (UMLS CUI [1])
C0021925 (UMLS CUI [2])
C0020440 (UMLS CUI [3])
pregnancy; lactating
Item
lactating, pregnant, or plans to become pregnant during the course of the trial
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial